Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct…
A new study has confirmed that a simple fix in the way patients are treated in emergency rooms (ERs) can speed up…
VERAXA Biotech is changing how antibody-based therapies recognize and attack cancer cells, developing antibody-based cancer therapies with an emphasis on…
Dr. David Morens, formerly an adviser to Anthony Fauci during the Covid-19 pandemic, has pleaded guilty to a charge of conspiracy to…
Earth Science Tech, an expanding health-based holding company, recently announced the acquisition of Meduvo LLC, a compounding pharmacy that currently…
MS drug development is increasingly expanding beyond controlling inflammation toward approaches designed to protect the nervous system and address mechanisms…
Glioblastoma is very difficult to treat because it quickly adapts and evolves to become resistant to existing treatments indicated for…
Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate…
Researchers from the University of Manchester in the UK have found that a small group of immune cells that aren’t given much…
Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the…